|
|||||
|
|
Molecular profiling and analysis of genetic aberrations aimed at identifying potential therapeutic targets in fibrolamellar carcinoma of the liver |
|
| Authors: | Imane El Dika MD Anita S Bowman MS Michael F Berger MD Marinela Capanu PhD Joanne F Chou MPH Ryma Benayed PhD Ahmet Zehir PhD Jinru Shia MD Eileen M O’Reilly MD David S Klimstra MD David B Solit MD Ghassan K Abou-Alfa MD MBA |
| Institution: | 1. Memorial Sloan Kettering Cancer Center, New York, New York, USA
Weill Cornell College of Medicine, New York, New York, USA;2. Memorial Sloan Kettering Cancer Center, New York, New York, USA |
| Abstract: | |
| Keywords: | catalytic subunit of protein kinase A (PRKACA) DNAJ homolog subfamily B member 1 (DNAJB1) fibrolamellar carcinoma (FLC) Memorial Sloan Kettering–Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT) TERT |